These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20110173)

  • 21. Desloratadine shows no effect on performance during 6 h at 8,000 ft simulated cabin altitude.
    Valk PJ; Van Roon DB; Simons RM; Rikken G
    Aviat Space Environ Med; 2004 May; 75(5):433-8. PubMed ID: 15152896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
    Kłos K; Kruszewski J; Kruszewski R; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Route to Prolonged Residence Time at the Histamine H
    Bosma R; Wang Z; Kooistra AJ; Bushby N; Kuhne S; van den Bor J; Waring MJ; de Graaf C; de Esch IJ; Vischer HF; Sheppard RJ; Wijtmans M; Leurs R
    J Med Chem; 2019 Jul; 62(14):6630-6644. PubMed ID: 31274307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
    Glass DJ; Harper AS
    BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the effect of prolonged use of desloratadine on adipose Brillouin shift and composition in rats.
    Troyanova-Wood M; Gobbell C; Meng Z; Gasheva O; Gashev A; Yakovlev VV
    J Biophotonics; 2021 Jan; 14(1):e202000269. PubMed ID: 32951319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of desloratadine on patients with allergic rhinitis and exercise-induced bronchoconstriction: a placebo controlled study.
    Manjra AI; Nel H; Maharaj B
    J Asthma; 2009 Mar; 46(2):156-9. PubMed ID: 19253122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and pharmacological investigation of novel 1-substituted-4-(4-substituted phenyl)-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as a new class of H1-antihistamine agents.
    Alagarsamy V; Giridhar R; Yadav MR
    J Pharm Pharmacol; 2006 Sep; 58(9):1249-55. PubMed ID: 16945184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: Implications for anti-inflammatory activity of antihistamines.
    Traidl-Hoffmann C; Münster I; Ring J; Behrendt H
    Int Arch Allergy Immunol; 2006; 140(4):315-20. PubMed ID: 16741367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving mechanical properties of desloratadine via multicomponent crystal formation.
    Ainurofiq A; Mauludin R; Mudhakir D; Umeda D; Soewandhi SN; Putra OD; Yonemochi E
    Eur J Pharm Sci; 2018 Jan; 111():65-72. PubMed ID: 28958892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid separation of desloratadine and related compounds in solid pharmaceutical formulation using gradient ion-pair chromatography.
    Zheng J; Rustum AM
    J Pharm Biomed Anal; 2010 Jan; 51(1):146-52. PubMed ID: 19748754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.
    Anthes JC; Gilchrest H; Richard C; Eckel S; Hesk D; West RE; Williams SM; Greenfeder S; Billah M; Kreutner W; Egan RE
    Eur J Pharmacol; 2002 Aug; 449(3):229-37. PubMed ID: 12167464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.
    Bosma R; Moritani R; Leurs R; Vischer HF
    Pharmacol Res; 2016 Sep; 111():679-687. PubMed ID: 27468652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extra- and intracellular oxidant production in phorbol myristate acetate stimulated human polymorphonuclear leukocytes: modulation by histamine and H(1)-antagonist loratadine.
    Drábiková K; Jancinová V; Nosál R; Pecivová J; Macicková T
    Inflamm Res; 2006 Apr; 55 Suppl 1():S19-20. PubMed ID: 16547821
    [No Abstract]   [Full Text] [Related]  

  • 34. Simultaneous determination of loratadine and desloratadine in pharmaceutical preparations using liquid chromatography with a microemulsion as eluent.
    El-Sherbiny DT; El-Enany N; Belal FF; Hansen SH
    J Pharm Biomed Anal; 2007 Mar; 43(4):1236-42. PubMed ID: 17126519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late-Stage Lead Diversification Coupled with Quantitative Nuclear Magnetic Resonance Spectroscopy to Identify New Structure-Activity Relationship Vectors at Nanomole-Scale Synthesis: Application to Loratadine, a Human Histamine H
    Lall MS; Bassyouni A; Bradow J; Brown M; Bundesmann M; Chen J; Ciszewski G; Hagen AE; Hyek D; Jenkinson S; Liu B; Obach RS; Pan S; Reilly U; Sach N; Smaltz DJ; Spracklin DK; Starr J; Wagenaar M; Walker GS
    J Med Chem; 2020 Jul; 63(13):7268-7292. PubMed ID: 32462865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Origin of the Distinct Tabletability of Loratadine and Desloratadine: Role of the Bonding Area - Bonding Strength Interplay.
    Shi Z; Wang C; Sun CC
    Pharm Res; 2020 Jun; 37(7):133. PubMed ID: 32596756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of desloratadine and alcohol coadministration on psychomotor performance.
    Scharf M; Berkowitz D
    Curr Med Res Opin; 2007 Feb; 23(2):313-21. PubMed ID: 17288686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis.
    Sullivan PW; Navaratnam P; Lorber R; Shekar T
    Curr Med Res Opin; 2010 Jun; 26(6):1389-97. PubMed ID: 20384438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
    Augustin M; Ehrle S
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.